Microvast Holdings Inc
For the period ended Mar 31, 2025. Filed May 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 12, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Unaudited Condensed Consolidated Financial Statements
NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Microvast, Inc. was incorporated under the laws of the State of Texas in the United States of America on October 12, 2006 and re-domiciled to the State of Delaware on December 31, 2015. On July 23, 2021 (the “Closing Date”), Microvast, Inc. and Tuscan Holdings Corp. (“Tuscan”) consummated the merger (the “Merger” or the "Business Combination"), pursuant to the Agreement and Plan of Merger (the “Merger Agreement”) dated February 1, 2021, between Tuscan, Microvast, Inc. and TSCN Merger Sub Inc., a Delaware corporation (“Merger Sub”).
Pursuant to the Merger Agreement, the Merger Sub merged with and into Microvast, Inc., with Microvast, Inc. surviving the Merger. As a result of the Merger, Tuscan was renamed “Microvast Holdings, Inc.” (the “Company”). The Merger was accounted for as a reverse recapitalization as Microvast, Inc. was determined to be the accounting acquirer under Financial Accounting Standards Board’s Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”).
The Company and its subsidiaries (collectively, the “Group”) are primarily engaged in developing, manufacturing, and selling lithium-ion battery technologies for use in commercial electric vehicles and battery energy storage systems across the globe.
NOTE 2. SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation and use of estimates
The accompanying unaudited condensed consolidated financial statements include the accounts of Microvast Holdings, Inc. and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
These financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”) applicable to interim financial reporting. Accordingly, certain information and disclosures normally included in the notes to the annual consolidated financial statements prepared in accordance with U.S. GAAP have been condensed or omitted.
These interim financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2024, included in the Annual Report on Form 10-K filed with the SEC on March 31, 2025, which contains a more complete discussion of the Company’s accounting policies and other relevant information.
In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the interim financial statements have been included. The results of operations for the three months ended March 31, 2025 are not necessarily indicative of results to be expected for any future interim period or the full fiscal year ending December 31, 2025.
The December 31, 2024 condensed consolidated balance sheet data included herein was derived from the Company’s audited financial statements.
There have been no material changes to the Company’s significant accounting policies as disclosed in Note 2 to the audited consolidated financial statements for the year ended December 31, 2024.
Significant accounting estimates include, but are not limited to, allowances for credit losses, write-down of obsolete inventories, impairment of property, plant and equipment, product warranties, fair value measurement of Convertible Loan and share based compensation. Actual results could differ materially from those estimates.
Going concern
The accompanying unaudited condensed consolidated financial statements of the Group have been prepared on a going concern basis, which assumes that the Group will continue to realize its assets and settle its liabilities in the ordinary course of business.
As of March 31, 2025, the Group had working capital of $108,086, stockholders’ equity of $454,235 (including an accumulated deficit of $1,031,168), and cash and cash equivalents of $90,898. As of March 31, 2025, the Group held outstanding borrowings of $127,543, with $86,241 due within the next 12 months, and other current liabilities of $253,665, which include accounts payable, notes payable, accrued expenses and other current liabilities. Additionally, as of March 31, 2025, the Group had $62,085 in purchase commitments primarily related to inventory, and $52,060 in capital commitments with $26,165 due within the next 12 months.
These conditions and events raise substantial doubt about the Group’s ability to continue as a going concern.
Management’s primary plans to alleviate the substantial doubt are as described below.
Forecasted cash inflow from operations - As of March 31, 2025, the Group has performed a review of its cash flow forecast for the next twelve months from the date of issuance of its unaudited condensed consolidated financial statements. For the three months ended March 31, 2025, the Group incurred net profit from operation of $18,932 and generated cash flow of $7,169 from its operating activities. The Group believes that its operating cash flow in the forecasted period will continue to grow. Management believes the forecast is based on reasonable assumptions including: i) there is no significant uncertainty on the execution of the existing contract backlog in the forecasted period, and ii) despite the potential fluctuation of the raw material prices, the gross margin in the forecasted period is not expected to significantly decline considering the selling price secured by the contract backlogs and the market conditions of major raw materials.
Refinancing of short-term bank borrowings - While there can be no assurance that the Group will be able to refinance its short-term bank borrowings as they become due, historically, the Group has rolled over or obtained replacement borrowings from existing creditors for its short-term bank loans upon the maturity date of the loans if needed. For $37,483 short-term bank borrowings outstanding as of March 31, 2025, for which the Company has successful refinancing experience, the Group assumes that it will continue to be able to do so for the next twelve months.
The below factors are considered by the management in assessing whether the plan is probable of being effectively implemented.
The refinancing of these loans have regularly occurred historically, even during the Group’s financially distressed periods.
These loans were borrowed by Microvast Power Systems Co., Ltd.('MPS'), the Group’s main operating subsidiary. MPS generated profit and positive cash flow during the twelve months ended December 31, 2024 and the three months ended March 31, 2025, and has shown improvement in operations comparing to the earlier periods.
In April and early May 2025, the Group successfully refinanced loans of $1,378 that matured.
The Group has established long-term relationships with those banks and has never defaulted on repayments historically.
Based on the above, the Group concluded that it is probable that management’s plans will alleviate the substantial doubt about the Group’s ability to continue as a going concern and that adequate sources of liquidity will exist to fund the Company’s working capital and capital expenditures requirements and to meet its short term debt obligations, and other liabilities and commitments as they become due. Therefore, the accompanying unaudited condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or to the amounts and classification of liabilities that might be necessary should the Group not continue as a going concern.
Revenue recognition
Nature of Goods and Services
The Group’s revenue consists primarily of sales of lithium-ion batteries. The obligation of the Group is to provide the battery products. Revenue is recognized at the point of time when control of the promised goods or services is transferred to the customer, in an amount that reflects the consideration the Group expects to be entitled to in exchange for the goods or services.
Disaggregation of revenue
For the three months ended March 31, 2025 and 2024, the Group derived revenues from geographic regions as follows:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| China | $44,126 | $27,192 |
| Other Asia & Pacific countries | 5,925 | 23,294 |
| Asia & Pacific | 50,051 | 50,486 |
| Europe | 60,050 | 28,921 |
| U.S. | 6,390 | 1,944 |
| Total | $116,491 | $81,351 |
Contract balances
Contract balances include accounts receivable and advances from customers. Accounts receivable represent cash not received from customers and are recorded when the rights to consideration are unconditional. The allowance for credit losses reflects the best estimate of probable losses inherent to the accounts receivable balance. Contract liabilities, recorded in advance from customers in the consolidated balance sheets, represent payment received in advance or payment received related to a material right provided to a customer to acquire additional goods or services at a discount in a future period. During the three months ended March 31, 2025 and 2024, the Group recognized $3,163 and $3,922 of revenue previously included in advance from customers as of January 1, 2025 and January 1, 2024, respectively.
Operating leases
The Company determines whether an arrangement is or contains a lease at inception. Operating leases are recognized in the condensed consolidated balance sheets as right-of-use (“ROU”) assets and lease liabilities, initially measured at the present value of lease payments over the lease term. As the rate implicit in the lease is not readily determinable, the Company uses its incremental borrowing rate based on information available at the commencement date. The rate is estimated using a portfolio approach that approximates the interest rate on a collateralized basis over similar terms and in a similar economic environment. Lease expense is recognized on a straight-line basis over the lease term.
The Company has elected the package of practical expedients permitted under ASC 842, which allows entities not to reassess:
Whether existing or expired contracts contain a lease;
Lease classification; and
Initial direct costs for any leases existing at the adoption date.
Operating leases - continued
Additionally, the Company elected the practical expedient not to separate lease and non-lease components, and for leases other than real estate (e.g., printing machines and electronic appliances) with terms of 12 months or less, elected the short-term lease exemption.
As of March 31, 2025, the Company recorded ROU assets of $18,205 and operating lease liabilities of $18,211, including current portion in the amount of $3,418, which was recorded under accrued expenses and other current liabilities on the balance sheet.
Lessor accounting
The Company also acts as a lessor, primarily through leasing arrangements with customers related to the sale of vehicles. These arrangements are classified as sales-type leases. Revenue from the sale of leased products is recognized at lease inception, and interest income is recognized over the lease term using the effective interest method. For the three months period ended March 31, 2025 and 2024, the Company recognize sales-type lease revenue $4,131 and $1,071 separately, which are included in products sales in the accompanying consolidated statements of operations. As of March 31, 2025, the Company recorded net investment in sales-type leases of $8,629 including current portion in the amount of $4,328, which was recorded under accounts receivables on the balance sheet.
Assets held for sale
Assets to be disposed of by sale are reported at the lower of the carrying value or fair value less cost to sell when the Company has committed to a sale agreement and such assets would be reported separately as assets held for sale in the unaudited condensed consolidated balance sheets.
Debt restructuring
A debt restructuring is the modification of debt in which a creditor grants a concession it would not otherwise consider to a debtor that is experiencing financial difficulties. These modifications may include an extension of the maturity date, a reduction of the face amount or maturity amount of the debt or a reduction of accrued interest. During the three months ended March 31, 2025, the Company recorded a gain of $389 on payable concessions in the unaudited condensed consolidated statements of operations.
Convertible Loan measured at fair value
The Company has elected the fair value option to account for the Convertible Loan (as defined below) described in Note 14 – Convertible loan measured at fair value herein, and records changes in fair value in the unaudited condensed consolidated statements of operations, with the exception of changes in fair value due to instrument-specific credit risk which, if present, will be recorded as a component of other comprehensive income. Interest expense related to the Convertible Loan is included in the changes in fair value. As a result of applying the fair value option, direct costs and fees related to the Convertible Loan was expensed as incurred. A gain of $42,934 was recognized for the three months ended March 31, 2025. The fair value of the Convertible Loan was determined by using a discounted cash flow model for the bond component and a Black-Scholes-Merton model for the conversion option, which is considered a Level 3 fair value measurement.
Warrant
The Company accounts for warrants in accordance with the guidance contained in ASC 815-40 under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. As the Private Warrants (as defined below in Note 10) meet the definition of a derivative as contemplated in ASC 815, the Company classifies the Private Warrants as liabilities. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the statements of operations. The Private Warrants are valued using a Monte Carlo simulation model on the basis of the quoted market price of the Company’s publicly-traded warrants.
Recent accounting pronouncements not yet adopted
In December 2023, the FASB issued ASU 2023-09 "Improvements to Income Tax Disclosures" ("ASU 2023-09"). ASU 2023-09 intends to improve the transparency of income tax disclosures. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024 and is to be adopted on a prospective basis with the option to apply retrospectively. The Company is currently assessing the impact of this guidance, however, the Company do not expect a material impact to the consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, "Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures" (Subtopic 220-40): Disaggregation of Income Statement Expenses. The amended guidance requires disaggregation of certain expense captions into specified natural expense categories in the disclosures within the notes to the financial statements. In addition, the guidance requires disclosure of selling expenses and its definition. The new guidance is effective for fiscal years beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The guidance can be applied either prospectively or retrospectively. The Company is currently assessing the impact of this guidance, however, the Company does not expect a material impact to the consolidated financial statements.
NOTE 3. ACCOUNTS RECEIVABLE
Accounts receivable consisted of the following:
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Accounts receivable | $142,177 | $125,716 |
| Allowance for credit losses | (6,523) | (5,090) |
| Accounts receivable, net | $135,654 | $120,626 |
Movement of allowance for credit losses was as follows:
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Balance at beginning of the period | $5,090 | $4,571 |
| Charges of expenses | 1,358 | 578 |
| Write off | — | — |
| Recoveries of credit losses | — | — |
| Exchange difference | 75 | (84) |
| Balance at end of the period | $6,523 | $5,065 |
NOTE 4. INVENTORIES, NET
Inventories consisted of the following:
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Work in process | $77,857 | $85,179 |
| Raw materials | 39,536 | 39,388 |
| Finished goods | 11,666 | 18,760 |
| Total | $129,059 | $143,327 |
No provision for obsolete inventories were recognized for the three months ended March 31, 2025 and 2024, respectively.
NOTE 5. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Payables for purchase of property, plant and equipment | $51,960 | $45,983 |
| Other current liabilities | 15,941 | 13,776 |
| Product warranty, current | 10,275 | 9,999 |
| Accrued expenses | 7,667 | 9,570 |
| Accrued payroll and welfare | 7,271 | 8,596 |
| Other tax payable | 6,978 | 7,399 |
| Operating lease liabilities, current | 3,418 | 3,039 |
| Interest payable | 626 | 94 |
| Total | $104,136 | $98,456 |
NOTE 6. PRODUCT WARRANTY
Movement of product warranty was as follows:
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Balance at beginning of the period | $33,107 | $35,217 |
| Provided during the period | 4,825 | 3,269 |
| Utilized during the period | (3,630) | (2,448) |
| Exchange difference | 359 | (590) |
| Balance at end of the period | $34,661 | $35,448 |
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Product warranty – current | $10,275 | $9,999 |
| Product warranty – non-current | 24,386 | 23,108 |
| Total | $34,661 | $33,107 |
NOTE 7. BANK BORROWINGS
On September 27, 2022, the Group entered into a $111,483 (RMB 800 million) loan facilities agreement with a group of lenders led by a bank in China (the "2022 Facility Agreement"). The interest rate is prime plus 115 basis points where prime is based on the Loan Prime Rate published by the National Inter-bank Funding Center of China and is payable on a quarterly basis. The loan facilities can only be used for the manufacturing capacity expansion at the Group’s facility located in Huzhou, China. The unutilized draw-down amount is recorded as non-current restricted cash. The Group had a balance of non-current restricted cash ofnil and $22 as of March 31, 2025 and December 31, 2024, respectively. The 2022 Facility Agreement contains certain customary restrictive covenants, including but not limited to disposal of assets and dividend distribution without the consent of the lender, and certain customary events of default.
As of March 31, 2025, the Group had outstanding borrowings of $68,838 under the 2022 Facility Agreement.
| Repayment Date | Repayment Amount |
|---|---|
| April 15, 2025 | $13,768 (RMB99.9 million) |
| December 10, 2025 | $13,768 (RMB99.9 million) |
| June 10, 2026 | $20,651 (RMB149.9 million) |
| December 10, 2026 | $20,651 (RMB149.9 million) |
The amount of capitalized interest expenses, which was recorded in construction in progress and property, plant and equipment, was $278 andnil for the three months ended March 31, 2025 and 2024, respectively.
The Group has also entered into short-term loan agreements and bank facilities with certain banks in China. The original terms of these loans are with a maximum maturity of 12 months and the interest rates range from 2.90% to 4.85% per annum. The amount of interest expenses, which was recorded in profit and loss was$390 and $240 for the three months ended March 31, 2025 and 2024, respectively.
Changes in bank borrowings are as follows:
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Beginning balance | $111,728 | $79,153 |
| Proceeds from bank borrowings | 28,187 | 18,780 |
| Repayments of principal | (13,062) | (12,520) |
| Exchange difference | 690 | (1,348) |
| Ending balance | $127,543 | $84,065 |
| Balance of bank borrowings includes: | March 31,2025 | December 31,2024 |
|---|---|---|
| Current | $86,241 | $70,666 |
| Non-current | 41,302 | 41,062 |
| Total | $127,543 | $111,728 |
NOTE 7. BANK BORROWINGS - continued
Certain assets of the Group have been pledged to secure the above bank facilities granted to the Group. The aggregate carrying amount of the assets pledged by the Group as of March 31, 2025 and December 31, 2024 are as follows:
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Buildings | $118,293 | $119,166 |
| Machinery and equipment | 59,752 | 60,991 |
| Land use rights | 11,366 | 11,371 |
| Construction in progress | 337 | 335 |
| Total | $189,748 | $191,863 |
NOTE 8. OTHER NON-CURRENT LIABILITIES
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Product warranty - non-current | $24,386 | $23,108 |
| Deferred subsidy income- non-current | 5,459 | 5,610 |
| Other non-current payable | — | 1,285 |
| Total | $29,845 | $30,003 |
NOTE 9. BONDS PAYABLE
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Long–term bonds payable | ||
| Huzhou Saiyuan | $41,693 | $43,157 |
| Total | $41,693 | $43,157 |
Huzhou Saiyuan Loan
On December 29, 2018, Microvast Power Systems Co., Ltd.("MPS"), one of the Company's subsidiaries, signed an agreement with Huzhou Saiyuan, an entity established by the local government, to issue convertible bonds to Huzhou Saiyuan for a total consideration of $87,776 (RMB 600 million). The Company pledged its 12.39% equity holding over MPS to Huzhou Saiyuan to facilitate the issuance of these convertible bonds.
If the subscribed bonds are not repaid by the maturity date, Huzhou Saiyuan has the right to dispose of the equity interests pledged by the Company in proportion to the amount of matured bonds, or convert the bonds into equity interests of MPS within 60 days after the maturity date. If Huzhou Saiyuan decides to convert the bonds into equity interests of MPS, the equity interests pledged would be released and the convertible bonds would be converted into equity interest of MPS based on an entity value of MPS of $950,000.
In September 2020 and 2022, MPS entered intotwo supplement agreements with Huzhou Saiyuan, respectively, to change the repayment schedule as follows: (i) $14,629 (RMB 100 million) was repaid, together with interest accrued, on or before November 10, 2022, (ii) $14,630 (RMB 100 million) was repaid, together with interest accrued, on or before December 31, 2022 and (iii) the remaining $43,888 (RMB 300 million) will be repaid, together with interest accrued, on or before January 31, 2027. The applicable interest rate will be increased to 12% if the Group is in default on the repayment of the bonds at the due date. The remaining terms and conditions of the convertible bonds were unchanged. The Company has fully complied with the amended repayment schedule.With $692 (RMB 5 million) repaid in 2023 and $1,375 (RMB 10 million) repaid in three months ended March 31, 2025, the subscription and outstanding balance of the convertible bonds was $41,693 (RMB 285 million) as of March 31, 2025.
NOTE 10. WARRANTS
The Company assumed 27,600,000 publicly-traded warrants (“Public Warrants”) and 837,000 private placement warrants issued to Tuscan Holdings Acquisition LLC (the “Sponsor”) and EarlyBirdCapital, Inc. (“EarlyBirdCapital”) (“Private Warrants” and together with the Public Warrants, the “Warrants”) upon the Business Combination, all of which were issued in connection with Tuscan’s initial public offering (other than 150,000 Private Warrants that were issued in connection with the closing of the Business Combination) and entitle the holder to purchaseone share of the Company’s Common Stock at an exercise price of $11.50 per share. During the three months ended March 31, 2025, none of the Public Warrants or the Private Warrants were exercised.
The Public Warrants became exercisable 30 days after the completion of the Business Combination. The Public Warrants are only exercisable for cash, however, if the Company were to not maintain the effectiveness of the registration statement covering the shares of Common Stock issuable upon exercise of the Public Warrants, the Public Warrants would be exercisable on a net-share settlement basis. The Public Warrants will expire five years after the completion of the Business Combination or earlier upon redemption or liquidation.
Once the Public Warrants became exercisable, the Company may redeem the Public Warrants:
in whole and not in part;
at a price of $0.01 per warrant;
upon not less than 30 days’ prior written notice of redemption;
if, and only if, the reported last sale price of the Company’s Common Stock equals or exceeds $18.00 per share for any 20-trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and
if, and only if, there is a current registration statement in effect with respect to the shares of Common Stock underlying the warrants.
If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a net-share settlement basis.
The Public Warrants were determined to be equity classified in accordance with ASC 815, Derivatives and Hedging.
The Private Warrants are identical to the Public Warrants, except that the Private Warrants will be exercisable for cash or on a net-share settlement basis, at the holder’s option, and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. In addition, so long as the Private Warrants are held by EarlyBirdCapital and its designee, the Private Warrants will expire five years from the effective date of the Business Combination.
The exercise price and number of shares of Common Stock issuable upon exercise of the Warrants may be adjusted in certain circumstances including in the event of a stock dividend, recapitalization, reorganization, merger or consolidation. However, the Warrants will not be adjusted for the issuance of Common Stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Warrants.
The Private Warrant liability was remeasured at fair value as of March 31, 2025, resulting in a gain of $226 and $42 for the three months ended March 31, 2025 and 2024 respectively. This was recorded within changes in fair value of warrant liability in the unaudited condensed consolidated statements of operations.
NOTE 10. WARRANTS - continued
The Private Warrants were valued using the following assumptions under the Monte Carlo Model that assumes optimal exercise of the Company’s redemption option at the earliest possible date:
| Market price of public stock | $1.17 |
|---|---|
| Exercise price | $11.50 |
| Expected term (years) | 1.32 |
| Volatility | 115.49% |
| Risk-free interest rate | 3.91% |
| Dividend rate | 0.00% |
The market price of public stock is the quoted market price of the Company’s Common Stock as of the valuation date. The exercise price is extracted from the warrant agreement. The expected term is derived from the exercisable years based on the warrant agreement. The expected volatility is a blend of implied volatility from the Company’s own public warrant pricing, the average volatility of peer companies and the Company's historical volatility. The risk-free interest rate was estimated based on the market yield of a U.S. Government Bond with a maturity close to the expected term of the warrants. The dividend yield was estimated by the Company based on its expected dividend policy over the expected term of the warrants.
On May 28, 2024, the Company also issued a warrant exercisable for 5,500,000 shares of Common Stock at an initial exercise price of $2.00 per share. The Warrant expires on May 28, 2029 in connection with the Convertible Loan. See Note 14 – Convertible loan measured at fair value.
NOTE 11. FAIR VALUE MEASUREMENT
Measured or disclosed at fair value on a recurring basis
The Group measured its financial assets and liabilities, including cash and cash equivalents, restricted cash, warrant liability and Convertible Loan at fair value on a recurring basis. Cash and cash equivalents and restricted cash are classified within Level 1 of the fair value hierarchy because they are valued based on the quoted market price in an active market. The fair value of the warrant liability and Convertible Loan are based on significant unobservable inputs, which represent Level 3 measurements within the fair value hierarchy. In determining the fair value of the warrant liability, the Company used the Monte Carlo Model that assumes optimal exercise of the Company’s redemption option at the earliest possible date. See Note 14 – Convertible loan measured at fair value for disclosure of valuation model utilized in measuring the fair value of Convertible Loan.
NOTE 11. FAIR VALUE MEASUREMENT - continued
Measured or disclosed at fair value on a recurring basis - continued
As of March 31, 2025 and December 31, 2024, information about inputs for the fair value measurements of the Group’s assets and liabilities that are measured at fair value on a recurring basis in periods subsequent to their initial recognition is as follows:
| Fair Value Measurement as of March 31, 2025 | ||||
|---|---|---|---|---|
| Quoted Prices in Active Market for Identical Assets (Level 1) | Significant OtherObservable Inputs(Level 2) | Significant Unobservable Inputs(Level 3) | Total | |
| Cash and cash equivalents | $90,898 | — | — | $90,898 |
| Restricted cash | 32,096 | — | — | 32,096 |
| Total financial asset | $122,994 | — | — | $122,994 |
| Warrant liability | $— | — | 64 | $64 |
| Convertible loan measured at fair value | — | — | 60,996 | 60,996 |
| Total financial liability | $— | — | 61,060 | $61,060 |
| Fair Value Measurement as of December 31, 2024 | ||||
|---|---|---|---|---|
| Quoted Prices in Active Market for Identical Assets (Level 1) | Significant OtherObservable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Total | |
| Cash and cash equivalents | $73,007 | — | — | $73,007 |
| Restricted cash | 36,594 | — | — | 36,594 |
| Total financial asset | $109,601 | — | — | $109,601 |
| Warrant liability | $— | — | 290 | $290 |
| Convertible loan measured at fair value | — | — | 104,613 | 104,613 |
| Total financial liability | $— | — | 104,903 | $104,903 |
The following is a reconciliation of the beginning and ending balances for Level 3 warrant liability during the three months ended March 31, 2025 and 2024:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Balance at beginning of the period | $290 | $67 |
| Changes in fair value | (226) | (42) |
| Balance at end of the period | $64 | $25 |
NOTE 11. FAIR VALUE MEASUREMENT - continued
Measured or disclosed at fair value on a recurring basis - continued
The following is a reconciliation of the beginning and ending balances for Level 3 Convertible Loan during the three months ended March 31, 2025:
| Three Months Ended March 31, 2025 | |
|---|---|
| Balance at the beginning of the period | $104,613 |
| Issuance of convertible loan | — |
| Interest paid during the period | (683) |
| Changes in fair value | (42,934) |
| Balance at end of the period | $60,996 |
Measured or disclosed at fair value on a nonrecurring basis
The Company’s assets measured at fair value on a nonrecurring basis include long-lived assets. The Company reviews the carrying amounts of such assets when events indicate that their carrying amounts may not be recoverable. Any resulting asset impairment would require that the asset be recorded at its fair value. The fair value of the asset or asset group is determined using cost approach, sales comparison approach and income capitalization approach with unobservable inputs (Level 3), depending on the underlying nature of the asset or the asset group.
NOTE 12. LEASES
The Group has operating leases for office spaces and warehouses. Certain leases include renewal options and/or termination options, which are factored into the Group's determination of lease payments when appropriate.
Operating lease cost for the three months ended March 31, 2025 was $857, which excluded cost of short-term contracts. Short-term lease cost for the three months ended March 31, 2025 was $46, respectively.
As of March 31, 2025, the weighted average remaining lease term was 8.9 years and weighted average discount rate was 5.1% for the Group's operating leases.
Supplemental cash flow information of the leases were as follows:
| Three Months Ended March 31, 2025 | |
|---|---|
| Cash payments for operating leases | $859 |
| Right-of-use assets obtained in exchange for new operating lease liabilities | $808 |
NOTE 12. LEASES - continued
The following is a maturity analysis of the annual undiscounted cash flows for lease liabilities as of March 31, 2025:
| As of March 31, 2025 | |
|---|---|
| Nine-month period ending December 31, 2025 | $3,330 |
| 2026 | 3,053 |
| 2027 | 2,592 |
| 2028 | 1,832 |
| 2029 | 1,640 |
| 2030 | 1,640 |
| Thereafter | 8,334 |
| Total future lease payments | $22,421 |
| Less: Imputed interest | $(4,210) |
| Present value of operating lease liabilities | $18,211 |
NOTE 13. SHARE-BASED PAYMENT
On July 21, 2021, the Company adopted the Microvast Holdings, Inc. 2021 Equity Incentive Plan (the “2021 Plan”), effective upon the Closing Date. The 2021 Plan provides for the grant of incentive and non-qualified stock options, restricted stock units, restricted share awards, stock appreciation awards, and cash-based awards to employees, directors, and consultants of the Company. Options awarded under the 2021 Plan expire no more than 10 years from the date of grant. Concurrently with the closing of the Business Combination, the share awards granted under 2012 Share Incentive Plan of Microvast, Inc. (the “2012 Plan”) were rolled over by removing original performance conditions and converting into options and capped non-vested share units with modified vesting schedules, using the Common Exchange Ratio of 160.3. The 2021 Plan reserved 5% of the fully-diluted shares of Common Stock outstanding immediately following the Closing Date plus the shares underlying the awards rolled over from the 2012 Plan for issuance in accordance with the 2021 Plan’s terms.
NOTE 13. SHARE-BASED PAYMENT - continued
Stock options
Stock options activity for the three months ended March 31, 2025 and 2024 was as follows:
| Stock options life | Number of Shares | Weighted Average Exercise Price (US$) | Weighted Average Grant Date Fair Value (US$) | Weighted Average Remaining Contractual Life |
|---|---|---|---|---|
| Outstanding as of December 31, 2024 | 32,701,399 | 5.80 | 4.58 | 4.5 |
| Exercised | (33,334) | 2.08 | 1.48 | |
| Forfeited | (3,066,072) | 6.18 | 4.83 | |
| Outstanding as of March 31, 2025 | 29,601,993 | 5.76 | 4.56 | 4.5 |
| Expected to vest and exercisable as of March 31, 2025 | 29,601,993 | 5.76 | 4.56 | 4.5 |
| Exercisable as of March 31, 2025 | 26,701,993 | 6.13 | 4.90 | 4.4 |
| Outstanding as of December 31, 2023 | 32,876,682 | 6.01 | 4.73 | 5.7 |
| Forfeited | (884,470) | 4.11 | 2.68 | |
| Outstanding as of March 31, 2024 | 31,992,212 | 6.06 | 4.78 | 5.5 |
| Expected to vest and exercisable as of March 31, 2024 | 31,992,212 | 6.06 | 4.78 | 5.5 |
| Exercisable as of March 31, 2024 | 20,875,499 | 6.13 | 4.88 | 5.5 |
During the three months ended March 31, 2025 and 2024, the Company recorded share-based compensation expense of $192 and $12,028 related to the option awards, respectively.
The total unrecognized equity-based compensation costs as of March 31, 2025 related to the stock options was $1,809, which is expected to be recognized over a weighted-average period of 1.7 years. The aggregate intrinsic value of the stock options as of March 31, 2025 wasnil.
Restricted stock units
Following the Business Combination, the Company granted 5,711,312 restricted stock units (“RSUs”) and 2,680,372 performance-based restricted stock units (“PSUs”) subject to service, performance and/or market conditions. The service condition requires the participant’s continued services or employment with the Company through the applicable vesting date, and the performance condition requires the achievement of the performance criteria defined in the award agreement. The market condition is based on the Company’s total stockholder return ("TSR") relative to a comparator group during a specified performance period.
The fair value of RSUs is determined by the market closing price of Common Stock at the grant date and is amortized over the vesting period on a straight-line basis. The fair value of PSUs that include vesting based on market conditions are estimated using the Monte Carlo valuation method. For PSUs with performance conditions, share-based compensation expense is only recognized if the performance conditions become probable to be satisfied. Compensation cost for these awards is amortized on a straight-line basis over the vesting period based on the grant date fair value, regardless of whether the market condition is satisfied. Accordingly, the Company recorded share-based compensation expense of $411 related to RSUs and $100 related to PSUs during the three months ended March 31, 2025. During the three months ended March 31, 2024, the Company recorded share-based compensation expense of $429 related to these RSUs and $(1,816) related to PSUs.
NOTE 13. SHARE-BASED PAYMENT - continued
Restricted stock units - continued
The non-vested shares activity for the three months ended March 31, 2025 and 2024 was as follows:
| Number ofNon-VestedShares | WeightedAverage GrantDate Fair ValuePer Share (U.S.$) | |
|---|---|---|
| Outstanding as of December 31, 2024 | 3,423,305 | 1.63 |
| Granted | 552,861 | 2.00 |
| Vested | (351,421) | 2.82 |
| Forfeited | (53,656) | 1.99 |
| Outstanding as of March 31, 2025 | 3,571,089 | 1.57 |
| Outstanding as of December 31, 2023 | 3,598,606 | 3.07 |
| Granted | 79,909 | 1.40 |
| Vested | (501,653) | 2.65 |
| Forfeited | (441,562) | 5.85 |
| Outstanding as of March 31, 2024 | 2,735,300 | 2.65 |
The total unrecognized equity-based compensation costs as of March 31, 2025 related to the non-vested shares was $3,804.
The following summarizes the classification of share-based compensation:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cost of revenues | $62 | $1,138 |
| General and administrative expenses | 437 | 8,167 |
| Research and development expenses | 150 | 1,777 |
| Selling and marketing expenses | 54 | 783 |
| Construction in process | — | 31 |
| Total | $703 | $11,896 |
NOTE 14. CONVERTIBLE LOAN MEASURED AT FAIR VALUE
On May 28, 2024, Microvast Holdings, Inc. entered into a $25,000 convertible loan agreement (the "Loan Agreement") with Mr. Yang Wu, the Company’s Chief Executive Officer and Chairman.
The loan includes an Initial Term Loan of $12,000 and a Delayed Draw Term Loan of $13,000 at an initial interest rate equal to the Secured Overnight Financing Rate ("SOFR"), plus an initial Applicable Margin of 9.75% per annum,3.75% of which shall be paid in kind rather than in cash (collectively, the "Convertible Loan"). The maturity date is May 28, 2026, which may be accelerated upon the occurrence and continuance of an event of default in accordance with the terms of the Loan Agreement. The Loan Agreement also provides Mr. Wu with the right to convert the outstanding principal balance of the Loan, into shares of common stock at an initial conversion rate equal totwo shares of Common Stock per $1.00 of principal amount to be converted.
The Initial Term Loans of $12,000 was received in May 2024 and the Delayed Draw Term loan of $13,000 was received in July 2024.
On March 17, 2025, the Company entered into the First Amendment to Loan and Security Agreement (the “First Amendment”) to its Loan and Security Agreement with Mr. Yang Wu. The First Amendment amends the Loan Agreement to extend the Maturity Date from November 28, 2025 to May 28, 2026. All other terms and conditions of the Loan Agreement remain the same. The modification of term is treated as a continuation of the original debt instrument.
The loan is secured by a first priority security interest in substantially all of its assets by Microvast Holdings, Inc. and all other entities within the Group as guarantors.
The Group has elected the fair value option to account for the convertible loan. Direct costs and fees related to the Convertible Loan were expensed as incurred. The fair value was determined by using a discounted cash flow model for the bond component and a Black-Scholes-Merton model for the conversion option, which is considered a Level 3 fair value measurement. Subsequent changes in the fair value are recorded as gains (losses) in the unaudited condensed consolidated statement of operation. During the three months ended March 31, 2025, a gain of $42,934 on fair value change of Convertible Loan was recorded, respectively. The outstanding balance for the Convertible Loan was $60,996 as of March 31, 2025.
In connection with the Convertible Loan on May 28, 2024, the Company issued to Mr. Wu a warrant exercisable for 5,500,000 shares of Common Stock at an initial exercise price of $2.00 per share. The warrant expires on May 28, 2029. No warrants were exercised during the period ended March 31, 2025. As of March 31, 2025,5,500,000 warrants were outstanding and the Group recorded the warrant value of $779 in additional paid in capital in the second quarter of 2024. Equity classified warrants were recorded at fair value at issuance with no changes recognized subsequent to the issuance date.
The significant input of the discounted cash flow model for the bond component is the discount rate. Below are the key inputs used in Black-Scholes-Merton model for the conversion option:
| Market price of public stock | $1.17 |
|---|---|
| Exercise price | $0.50 |
| Expected term (years) | 1.16 |
| Volatility | 75.70% |
| Risk-free interest rate | 3.93% |
| Dividend rate | 0.00% |
NOTE 14. CONVERTIBLE LOAN MEASURED AT FAIR VALUE - continued
The market price of public stock is the quoted market price of the Company’s Common Stock as of the valuation date. The exercise price is extracted from the warrant agreement. The expected term is derived from the exercisable years based on the warrant agreement. The expected volatility is estimated using a blend of the average volatility of peer companies and the Company's historical volatility. The risk-free interest rate was estimated based on the market yield of U.S. Government Bond with maturity close to the expected term of the warrants. The dividend yield was estimated by the Company based on its expected dividend policy over the expected term of the warrants.
NOTE 15. NET PROFIT/(LOSS) PER SHARE
The following table sets forth the computation of basic and diluted net profit/(loss) per share for the periods indicated:
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Numerator: | ||
| Net profit/(loss) attributable to common share stockholders-Basic | $61,790 | $(24,825) |
| Changes in fair value of convertible loan | (42,934) | — |
| Net profit/(loss) attributable to common share stockholders-Dilutive | $18,856 | $(24,825) |
| Denominator: | ||
| Weighted average common stock used in computing basic net profit/(loss) per share | 323,430,721 | 315,367,121 |
| Weighted-average effect of dilutive stocks: | ||
| Add: | ||
| Diluted effect of shares issuable upon exercise of stock options | 11,445 | — |
| Diluted effect of shares issuable upon exercise of non-vested shares | 982,860 | — |
| Diluted effect of shares issuable upon conversion of convertible loan | 50,000,000 | — |
| Weighted average stock used in computing diluted net profit/(loss) per share | 374,425,026 | 315,367,121 |
| Basic net profit/(loss) per share | $0.19 | $(0.08) |
| Diluted net profit/(loss) per share | $0.05 | $(0.08) |
For the three months ended March 31, 2025 and 2024, the following shares of Common Stock outstanding were excluded from the calculation of diluted net profit/(loss) per share, as their inclusion would have been anti-dilutive for the periods prescribed.
| Three Months Ended March 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Shares issuable upon exercise of stock options | 30,876,236 | 32,249,831 |
| Shares issuable upon vesting of non-vested shares | 884,206 | 2,965,761 |
| Shares issuable upon vesting of capped non-vested shares | — | 6,617,351 |
| Shares issuable upon exercise of warrants | 33,937,000 | 28,437,000 |
| Shares issuable upon vesting of earn-out shares | — | 19,999,988 |
| Shares issuable that may be subject to cancellation | 1,687,500 | 1,687,500 |
NOTE 16. COMMITMENTS AND CONTINGENCIES
Litigation
Corporate Governance Actions
Stephen Vogel, Ruth Epstein, Stefan Selig, Richard Rieger, Amy Butte, Yang Wu and Yanzhuan Zheng have been named as defendants in a litigation filed in the Court of Chancery captioned Matt Jacob v. Stephen A. Vogel, et al., C.A. No. 2022-0600-PAF (Del. Ch.) (filed July 07, 2022). The plaintiff is seeking to certify the litigation as a stockholder class action. The complaint alleges that Stephen Vogel, Ruth Epstein, Stefan Selig, Richard Rieger and Amy Butte breached their fiduciary duties in connection with Tuscan's acquisition of Microvast, Inc., including by making inadequate disclosures concerning the projected earnings of Microvast, Inc. The complaint further alleges that once the earnings of the combined company became public, the Company's stock dropped, causing losses to investors. The complaint also alleges that Yang Wu and Yanzhuan Zheng aided and abetted these purported breaches. Certain defendants have answered the complaint, and certain defendants have filed motions to dismiss, which they argued on April 03, 2025. The Court has not yet decided those motions.
On December 13, 2023, in response to a stockholder litigation demand, the Company filed a petition in the Court of Chancery pursuant to Section 205 of the Delaware General Corporation Law seeking validation of an amendment to the Company’s Amended Certificate of Incorporation, the Business Combination and the issuance of the shares issued pursuant thereto, and the Company’s Second Amended and Restated Certificate of Incorporation adopted in connection with the Business Combination (collectively, the "Acts") to resolve any uncertainty with respect to those matters, which action was captioned In re Microvast Holdings Inc., C.A. No. 2023-1245-PAF. On March 18, 2024, the Court of Chancery granted the petition, validating and declaring effective each Act as of the time and date such Act was originally taken.
The Company, the directors of the Company predecessor, Tuscan, and certain former and current Company officers and directors have also been named as defendants in a litigation filed in the Court of Chancery captioned Denish Bhavsar v. Stephen Vogel, et al., Case No. 2024-0137-PAF (Del. Ch.) (filed Feb. 14, 2024). The plaintiff purports to assert derivative claims on behalf of the Company. The complaint alleges that the individual defendants breached their fiduciary duties in connection with Tuscan’s acquisition of Microvast, Inc., including by making inadequate disclosures concerning Microvast, Inc.’s earnings and alleged conflicts of interest that existed between certain directors and Company stockholders.
The Company, and certain former and current Company officers and directors have also been named as defendants in a litigation filed in the Court of Chancery captioned Henry Park v. Yang Wu, et al., C.A. No. 2024-0868-PAF (Del. Ch.) (filed August 19, 2024). The plaintiff purports to assert derivative claims on behalf of the Company. The complaint alleges that certain individual defendants breached their fiduciary duties in connection with Tuscan’s acquisition of Microvast, Inc., including by making inadequate disclosures concerning Microvast, Inc.’s earnings and by refusing to investigate a litigation demand. On October 14, 2024, the Company and other defendants filed a motion to dismiss but the judge has not yet ruled on the motion.
The Company has received additional demands from purported Company stockholders, requesting that the Company’s Board of Directors investigate whether current and former directors and officers of the Company and its predecessors, Tuscan and Microvast Inc., breached their fiduciary duties by allegedly making material misrepresentations about inter alia (1) Microvast Inc.’s performance and financial health in connection with the merger between Tuscan and Microvast, Inc., and (2) the Company’s loss of a conditional grant from the United States Department of Energy. The Company has responded to certain of the demands and is evaluating responses to others. The Company has also received and responded to a stockholder demand for books and records made pursuant to Section 220 of the Delaware General Corporation Law that purportedly seeks to investigate the loss of the DOE grant.
NOTE 16. COMMITMENTS AND CONTINGENCIES- continued
Securities Litigation
The Company and certain of its officers have also been named as defendants in a putative class action complaint by a stockholder of the Company in the U.S. District Court for the Southern District of Texas under the caption Schelling v. Microvast Holdings, Inc., Case No. 4:23-cv-04565 (S.D. Tex.) (filed Dec. 5, 2023) (the "Schelling Action"). The complaint alleges that defendants violated certain federal securities laws by making misleading statements regarding the receipt of a conditional grant from the United States Department of Energy, the Company’s profitability, and the nature of Company-associated operations in China. On March 1, 2024, the court appointed Co-Lead Plaintiffs and Co-Lead Counsel for the proposed class of Company investors. Plaintiffs amended their complaint on May 13, 2024, and Defendants filed a
motion to dismiss on June 20, 2024. Briefing on the motion to dismiss was completed on September 10, 2024. The Court has scheduled a hearing on the motion to dismiss for Monday, May 19, 2025.
The Company and certain of its officers and directors have also been named as defendants inthree derivative actions filed in the Southern District of Texas under the captions Bhavsar v. Wu et al., No. 4:24-cv-00372 (S.D. Tex.) (filed Jan. 31, 2024), Marti et al v. Wu et al, Case No. 4:24-cv-00633 (S.D. Tex.) (filed Feb. 23, 2024), Gidaro v. Wu et al, Case No. 4:24-cv-00828 (S.D. Tex.) (filed Mar. 6, 2024). The complaints allege that the officer and director defendants violated the federal securities laws by making inadequate disclosures substantially similar to those alleged in the Schelling Action. The complaints further allege that these inadequate disclosures resulted from, and constituted, breaches of the officer and director defendants’ fiduciary duties. On February 24, 2024, the court entered in an order in the first-filed case, Bhavsar v. Wu et al., No. 4:24-cv-00372, consolidating the Bhavsar case and Marti et al v. Wu et al, Case No. 4:24-cv-00633. The consolidated derivative litigation (the “Consolidated Derivative Action”) is captioned In re Microvast Holdings, Inc. Derivative Litigation, Lead Case No. 4:24-cv-00372 (S.D. Tex.). The parties in the Gidardo action filed a stipulation to consolidate the Gidaro case into the Consolidated Derivative Action. The Consolidated Derivative Action is stayed pending disposition of an anticipated motion to dismiss in the Schelling Action.
Pursuant to the Company's governing documents and indemnification agreements entered into by the Company with certain of the named defendants, in the above-described actions, the Company has indemnified those defendants for all expenses and losses related to the litigation subject to the terms of those indemnification agreements. While the lawsuits are being vigorously defended, other reported lawsuits of this type have resulted in a broad range of outcomes, with each case being dependent on its own unique set of facts and circumstances. Litigation of this kind can lead to settlement negotiations, including negotiations prompted by pre-trial civil court procedures. The outcome of any litigation is inherently uncertain, and there is always the possibility that a court rules in a manner that is adverse to the interests of the Company and the individual defendants. However, the amount of any such loss in that scenario, which could be material, cannot be reasonably estimated at this time.
Other Matters
The Company and Microvast Energy, Inc. (“Microvast Energy”), a subsidiary of the Company, have been named as defendants in a litigation filed in the Chancery Court for the State of Tennessee under the caption Stoncor Group, Inc. v. Microvast, Inc., et al, Case No. CD-24-12 (Tenn. Ch.) (filed Mar. 18, 2024). The plaintiff alleges that the Company failed to pay it for construction work that it performed on a Microvast facility in Tennessee, and seeks damages of $1,251, plus certain fees and expenses, and foreclosure on the facility to satisfy the payment allegedly owed. The Parties entered into a settlement agreement and this matter has been stayed by order of the court.
Deidra Milan is an ex-employee of Microvast, and is the putative representative of a class of individual employees who were let go from their jobs at a plant in Clarksville, Tennessee. She has filed Civil Action No. 3:24-cv-00627, Deidre Milan, Plaintiff v. Microvast, Inc. and Microvast Holdings, Inc. in the US District Court for the Middle District of Tennessee. The Company filed an answer to the suit on July 19, 2024. The Class Action Complaint is brought under the Worker Adjustment and Notification Act, 29 U.S.C. §§2101-2109 (the “WARN Act”), which requires advance notice before certain types of plant closings and mass layoffs. Plaintiff alleges that Defendants failed to give proper advance notice of a mass layoff in violation of the WARN Act. Plaintiffs seek backpay, medical expenses, attorney’s fees and statutory penalties in an unspecified amount.
NOTE 16. COMMITMENTS AND CONTINGENCIES- continued
Other Matters-continued
Microvast, Inc., a subsidiary of the Company, has been named as a defendant in a contract dispute litigation filed in Montgomery County Chancery Court for the State of Tennessee under the caption DPR Construction, GP vs. Microvast, Inc., et al, Case No. CD-24-31 (Tenn. Ch.) (filed June 20, 2024). The Plaintiff alleges that the Company failed to pay it for construction work that is performed on a Microvast facility in Tennessee, and seeks damages of $19,950 in progress billings, the additional sum of $1,566 being held as retainage on Plaintiff's progress billings under the contract, lost profits on the work yet to be performed under the contract plus certain fees and expenses, and foreclosure on the facility to satisfy the payment allegedly owed. The Parties entered into a settlement agreement and on November 11, 2024, this matter was stayed by the order of the court.
Microvast, Inc. has been named as a defendant in a contract dispute litigation filed in Montgomery County Chancery Court for the State of Tennessee under the caption Faith Technologies, Inc. Microvast, Inc. et al., Case No. CD-24-36 (Tenn. Ch.) (filed on July 15, 2024). Plaintiff asserts claims for damages related to its subcontract with DPR Construction, GP under which Plaintiff provided fire protection system services on a Microvast facility in Tennessee, and seeks damages of $1,699 plus cost of court and attorneys and prejudgment interest. The Parties entered into a settlement agreement and on November 11, 2024, this matter was stayed by order of the court.
Microvast, Inc. was named as a defendant in an action filed in Montgomery County Chancery Court for the State of Tennessee under the caption Bernhard MCC, LLC. vs. U.S. Engineering Innovations, LLC, DPR Construction, Microvast, Inc. and the Industrial Development Board of the County of Montgomery, Case No. CD-24-27 (Tenn. Ch.) (filed on May 28, 2024 ) brought by a subcontractor on the Microvast Facility in Tennessee for lien enforcement of $5,681. The Parties entered into a settlement agreement and this matter has been stayed by order of the court.
Microvast, Inc. was named as a defendant in an action filed in Montgomery County Chancery Court for the State of Tennessee under the caption Virginia Transformer Corp. v. Microvast, Inc.and the Industrial Development Board of the County of Montgomery, Tennessee, Case No. RE-24-32 (Tenn. Ch.) (filed on July 01, 2024) brought by a prime contractor on the Microvast Facility in Tennessee for lien enforcement of $1,769. The Parties entered into a settlement agreement and this matter has been stayed by order of the court. Plaintiff has filed a motion to lift the stay and to amend its complaint to add a claim for breach of the settlement agreement. That motion remains pending.
Microvast, Inc. has initiated a lawsuit as a plaintiff in an action filed in the 11th Judicial District Court, Harris County, Texas under the caption Microvast, Inc. v. Grupo Basan Barba Santana, S.A. De C.V., Cause No. 2025-11326 (filed on February 19, 2025). Microvast ordered and paid energy storage systems from Grupo Basan. Microvast ended the supply contract and under the supply contract, Microvast was entitled to the return of a large portion of the $3.5 million deposit Microvast had paid Grupo Basan as well as compensation for a significant number of products that it never received. However, Grupo Basan not only has failed to return those funds, but Grupo Basan has itself demanded $2.4 million in million in termination costs that are not provided for in the supply agreement. Microvast recently filed suit in Harris County, Texas seeking at least $2.6 million plus fees and interest.
On November 14, 2024, Microvast Energy, Inc. was named as a defendant in breach of contract action filed before the American Arbitration Association (“AAA”) under the caption Clenera Battery Holdco LLC v. Microvast, Inc.., Case No. 01-24-0008-7288. Clenera's breach of contract claim centers on a supply agreement between Microvast and Clenera for custom-made battery containers. Clenera alleges that Microvast must refund approximately$36 million due to Microvast's failure to deliver the containers by the contractual deadline, per the terms of the supply agreement. Clenera also seeks interest and attorneys’ fees. The parties have appointed their arbitrators and a chair has been selected. On November 15, 2024, Clenera had filed an action for the same claim against Microvast Holdings, Inc. in the Supreme Court of the State of New York, County of New York, under the caption Clenera Battery Holdco LLC v. Microvast Holdings, Inc., Index No. 659103/2024. The guaranty action has been consolidated into the arbitration.
NOTE 16. COMMITMENTS AND CONTINGENCIES - continued
Other Matters-continued
The Group is also involved in other litigation, claims, and proceedings. The Group evaluates the status of each legal matter and assesses the potential financial exposure. If the potential loss from any legal proceedings or litigation is considered probable and the amount can be reasonably estimated, the Group accrues a liability for the estimated loss. Significant judgment is required to determine the probability of a loss and whether the amount of the loss is reasonably estimated. As of March 31, 2025 and December 31, 2024, based on the information currently available, the Group believes that any loss contingencies that may arise as a result of currently pending legal proceedings cannot be accurately quantified at this time and thus cannot determine whether they will have a material adverse effect on the Group’s business, results of operations, financial condition, and cash flows.
Capital commitments
Capital commitments for construction of property and purchase of property, plant and equipment were $52,060 as of March 31, 2025.
Purchase commitments
Purchase commitments for non-cancelable contractual obligations primarily related to purchases of inventory were $62,085 as of March 31, 2025.
Pledged assets
Other than those disclosed in Note 7 - Bank Borrowings, the Group may pledge certain assets to banks to secure the issuance of bank acceptance notes for the Group. As of March 31, 2025, certain of the Group's machinery and equipment with a carrying value of $23,016 has been pledged to secure the issuance of such notes.
Liens
As of March 31, 2025, the Company had received $24,287 of liens.
NOTE 17. SEGMENT INFORMATION
Operating segments are defined as components of an enterprise engaging in businesses activities for which separate financial information is available that is regularly evaluated by the Group’s chief operating decision makers (“CODM”) in deciding how to allocate resources and assess performance. The Group’s CODM has been identified as the Chief Executive Officer (“CEO”), who uses consolidated net profit or loss to measure segment profit or loss, allocate resources, and assess performance. The CODM is regularly provided with the consolidated statements of operations and uses consolidated net profit or loss to monitor budget versus actual results when making decisions about the allocation of operating and capital resources. As such, the Group concluded that it hasone operating segment andone reporting segment. Significant segment expenses were the same as those presented under the cost of revenues and operating expenses in the unaudited condensed consolidated statements of operations. Other segment items included in consolidated net income were subsidiary income, interest income, interest expense, change in fair value of warrant liability and convertible loan, gain on debt restructuring, other income/(expense) in the accompanying unaudited condensed consolidated statements of operations.
NOTE 18. SUBSEQUENT EVENTS
Subsequent funding activities
From first quarter end to the date of issuance of the financial statements in this Report, the Company received $1,378 of short-term bank borrowings. The term of this loan is 12 months and the interest rates is 4.5% per annum.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.